Rissing J P, Buxton T B, Harris R W, Shockley R K
J Infect Dis. 1984 Jun;149(6):929-34. doi: 10.1093/infdis/149.6.929.
An indirect enzyme-linked immunosorbent assay was developed to detect specific Bacteroides fragilis antigen(s) in human urine. Specimens collected within 72 hr of a positive culture were centrifuged, dialyzed, and treated with Tween 20, polyethylene glycol, and bovine serum albumin. Goat hyperimmune gamma-globulin to B. fragilis strain ATCC 23745 was added and incubated, and supernatants were tested for antibody activity to polysaccharide-protein antigen of the same organism. Mean +/- SD results, reported as percentage inhibition of control values and interpreted blindly, were as follows: 29 normal subjects, 9.8% +/- 6.0%; 22 patients with Enterobacteriaceae bacteremia, 6.0% +/- 5.1%; six patients with nonbacteremic infections due to B. fragilis, 22.3% +/- 10.3%; and nine patients with B. fragilis bacteremia, 28.7% +/- 10.2%. Three of six nonbacteremic patients and eight of nine bacteremic patients yielded values greater than 2 SD of control values. None of 22 patients with Enterobacteriaceae bacteremia was falsely positive (specificity, 100%).
开发了一种间接酶联免疫吸附测定法,用于检测人尿中的脆弱拟杆菌特异性抗原。在阳性培养后72小时内收集的标本进行离心、透析,并用吐温20、聚乙二醇和牛血清白蛋白处理。加入针对脆弱拟杆菌菌株ATCC 23745的山羊超免疫γ球蛋白并孵育,然后检测上清液对同一生物体多糖 - 蛋白质抗原的抗体活性。以对照值抑制百分比报告并进行盲法解释的平均±标准差结果如下:29名正常受试者,9.8%±6.0%;22名肠杆菌科菌血症患者,6.0%±5.1%;6名因脆弱拟杆菌导致的非菌血症感染患者,22.3%±10.3%;9名脆弱拟杆菌菌血症患者,28.7%±10.2%。6名非菌血症患者中有3名以及9名菌血症患者中有8名的值高于对照值的2个标准差。22名肠杆菌科菌血症患者中无一例假阳性(特异性为100%)。